1. Autologous haematopoietic stem cell transplantation compared with alemtuzumab for relapsing–remitting multiple sclerosis: an observational study. Issue 2 (26th October 2020) Authors: Zhukovsky, Christina; Sandgren, Sofia; Silfverberg, Thomas; Einarsdottir, Sigrun; Tolf, Andreas; Landtblom, Anne-Marie; Novakova, Lenka; Axelsson, Markus; Malmestrom, Clas; Cherif, Honar; Carlson, Kristina; Lycke, Jan; Burman, Joachim Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 92:Issue 2(2021) Page Start: 189 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Cerebrospinal fluid biomarkers as a measure of disease activity and treatment efficacy in relapsing‐remitting multiple sclerosis. Issue 2 (29th November 2016) Authors: Novakova, Lenka; Axelsson, Markus; Khademi, Mohsen; Zetterberg, Henrik; Blennow, Kaj; Malmeström, Clas; Piehl, Fredrik; Olsson, Tomas; Lycke, Jan Journal: Journal of neurochemistry Issue: Volume 141:Issue 2(2017) Page Start: 296 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Cerebrospinal fluid biomarkers of inflammation and degeneration as measures of fingolimod efficacy in multiple sclerosis. (January 2017) Authors: Novakova, Lenka; Axelsson, Markus; Khademi, Mohsen; Zetterberg, Henrik; Blennow, Kaj; Malmeström, Clas; Piehl, Fredrik; Olsson, Tomas; Lycke, Jan Journal: Multiple sclerosis Issue: Volume 23:Number 1(2017) Page Start: 62 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Cerebrospinal fluid NCAM levels are modulated by disease‐modifying therapies. (5th March 2019) Authors: Axelsson, Markus; Dubuisson, Nicolas; Novakova, Lenka; Malmeström, Clas; Giovannoni, Gavin; Lycke, Jan; Gnanapavan, Sharmilee Journal: Acta neurologica Scandinavica Issue: Volume 139:Number 5(2019) Page Start: 422 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Cerebrospinal fluid neurofilament light and tau protein as mortality biomarkers in parkinsonism. (20th May 2019) Authors: Constantinescu, Radu; Rosengren, Lars; Eriksson, Barbro; Blennow, Kaj; Axelsson, Markus Journal: Acta neurologica Scandinavica Issue: Volume 140:Number 2(2019) Page Start: 147 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Cranial neuropathy in the blue rubber bleb nevus syndrome. Issue 11 (27th June 2010) Authors: Kondziella, Daniel; Nordanstig, Annika; Mölne, Lena; Axelsson, Markus Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 81:Issue 11(2010) Page Start: 1207 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Exploring CSF neurofilament light as a biomarker for MS in clinical practice; a retrospective registry-based study. (May 2022) Authors: Rosenstein, Igal; Axelsson, Markus; Novakova, Lenka; Blennow, Kaj; Zetterberg, Henrik; Lycke, Jan Journal: Multiple sclerosis Issue: Volume 28:Number 6(2022) Page Start: 872 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Fatigue, insomnia and daytime sleepiness in multiple sclerosis versus narcolepsy. (19th July 2021) Authors: Johansson, Kalle; Wasling, Pontus; Axelsson, Markus Journal: Acta neurologica Scandinavica Issue: Volume 144:Number 5(2021) Page Start: 566 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Immunosuppressive therapy reduces axonal damage in progressive multiple sclerosis. (January 2014) Authors: Axelsson, Markus; Malmeström, Clas; Gunnarsson, Martin; Zetterberg, Henrik; Sundström, Peter; Lycke, Jan; Svenningsson, Anders Journal: Multiple sclerosis Issue: Volume 20:Number 1(2014) Page Start: 43 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Intrathecal immunoreactivity in people with or without previous infectious mononucleosis. (10th June 2020) Authors: Jons, Daniel; Zetterberg, Henrik; Malmeström, Clas; Bergström, Tomas; Axelsson, Markus; Blennow, Kaj; Thulin, Måns; Sundström, Peter; Andersen, Oluf Journal: Acta neurologica Scandinavica Issue: Volume 142:Number 2(2020) Page Start: 161 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗